The very first cancer genome (the whole thing) has been sequenced. Step 2: figuring out the difference between the non-cancer version and cancerous version.
That second step is not as straightforward has it sounds. There will be lots of difference that are not cancer related. In fact, this sequence is also of a female and all the known non-cancer sequences are of males. Seriously, wouldn’t this complicate the analysis? In general, you try to reduce the number of variable in a comparitive analysis. But, I’m not a geneticist, so maybe its not big deal.
Anyway, kudos to this. Hope to see results before too long.